Taiwan · Delayed Price · Currency is TWD SunWay Biotech Co., LTD. Statistics
Total Valuation
TPEX:1271 has a market cap or net worth of TWD 4.48 billion. The enterprise value is 4.35 billion.
| Market Cap | 4.48B |
| Enterprise Value | 4.35B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | Jul 16, 2025 |
Share Statistics
TPEX:1271 has 60.39 million shares outstanding. The number of shares has increased by 20.64% in one year.
| Current Share Class | 60.39M |
| Shares Outstanding | 60.39M |
| Shares Change (YoY) | +20.64% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 6.89% |
| Owned by Institutions (%) | n/a |
| Float | 28.77M |
Valuation Ratios
The trailing PE ratio is 52.95.
| PE Ratio | 52.95 |
| Forward PE | n/a |
| PS Ratio | 4.71 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 5.42 |
| P/FCF Ratio | 44.84 |
| P/OCF Ratio | 22.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.30, with an EV/FCF ratio of 43.49.
| EV / Earnings | 51.22 |
| EV / Sales | 4.57 |
| EV / EBITDA | 23.30 |
| EV / EBIT | 39.81 |
| EV / FCF | 43.49 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.17.
| Current Ratio | 1.93 |
| Quick Ratio | 1.47 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 2.92 |
| Debt / FCF | 5.44 |
| Interest Coverage | 21.06 |
Financial Efficiency
Return on equity (ROE) is 2.64% and return on invested capital (ROIC) is 1.87%.
| Return on Equity (ROE) | 2.64% |
| Return on Assets (ROA) | 1.73% |
| Return on Invested Capital (ROIC) | 1.87% |
| Return on Capital Employed (ROCE) | 3.07% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | 1.71 |
Taxes
In the past 12 months, TPEX:1271 has paid 21.51 million in taxes.
| Income Tax | 21.51M |
| Effective Tax Rate | 20.22% |
Stock Price Statistics
The stock price has decreased by -15.26% in the last 52 weeks. The beta is -0.10, so TPEX:1271's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | -15.26% |
| 50-Day Moving Average | 72.60 |
| 200-Day Moving Average | 70.37 |
| Relative Strength Index (RSI) | 46.80 |
| Average Volume (20 Days) | 73,565 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1271 had revenue of TWD 951.52 million and earned 84.86 million in profits. Earnings per share was 1.40.
| Revenue | 951.52M |
| Gross Profit | 541.16M |
| Operating Income | 108.82M |
| Pretax Income | 106.37M |
| Net Income | 84.86M |
| EBITDA | 150.98M |
| EBIT | 108.82M |
| Earnings Per Share (EPS) | 1.40 |
Balance Sheet
The company has 680.88 million in cash and 543.57 million in debt, giving a net cash position of 137.31 million or 2.27 per share.
| Cash & Cash Equivalents | 680.88M |
| Total Debt | 543.57M |
| Net Cash | 137.31M |
| Net Cash Per Share | 2.27 |
| Equity (Book Value) | 3.23B |
| Book Value Per Share | 53.39 |
| Working Capital | 575.41M |
Cash Flow
In the last 12 months, operating cash flow was 202.97 million and capital expenditures -103.04 million, giving a free cash flow of 99.93 million.
| Operating Cash Flow | 202.97M |
| Capital Expenditures | -103.04M |
| Free Cash Flow | 99.93M |
| FCF Per Share | 1.65 |
Margins
Gross margin is 56.87%, with operating and profit margins of 11.44% and 8.92%.
| Gross Margin | 56.87% |
| Operating Margin | 11.44% |
| Pretax Margin | 11.18% |
| Profit Margin | 8.92% |
| EBITDA Margin | 15.87% |
| EBIT Margin | 11.44% |
| FCF Margin | 10.50% |
Dividends & Yields
This stock pays an annual dividend of 1.33, which amounts to a dividend yield of 1.77%.
| Dividend Per Share | 1.33 |
| Dividend Yield | 1.77% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.64% |
| Shareholder Yield | -18.84% |
| Earnings Yield | 1.89% |
| FCF Yield | 2.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 9, 2024. It was a forward split with a ratio of 1.0168388514.
| Last Split Date | Dec 9, 2024 |
| Split Type | Forward |
| Split Ratio | 1.0168388514 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |